Title of Webinar
Novel Oral Anticoagulants: Benefits and Risks; March 6, 2015
Program Faculty
Allison Strobel PharmD, BCACP
Hardware and Software Requirements
The online courses offered on this website require a computer/tablet using the Windows Operating System (XP, 7,8) or a computer/tablet using the Apple
OS 10 or higher Operating System or iOS 5 (or higher). Courses will require a web browser including Internet Explorer version 7 or higher, Safari 5, Mozilla
Firefox version 3.5 or higher, or Google Chrome 3 or higher.
Certain activities may require additional software to view multimedia, presentations, or printable versions of the content. These activities will be marked
as such and will provide links to the required software.
Continuing Education Credits
You need to view the entire program to receive credit (approximately 1 hour total). You will then be directed to a link for the post test and evaluation. To
receive credit, you will need to correctly answer four of the questions on the post-test. Upon successful completion of the post test, and completion of the
evaluation, a certificate will be sent to email address you provided. You will have three opportunities to complete the post test.
Nursing Credit
•
Midwest Multistate Division designates this activity for 0.75 contact hour(s) for nurses. Nurses should only claim credit
commensurate with the extent of their participation in the activity.
•
Nurses licensed in Iowa and California: This activity was planned and developed in accordance with the continuing education
standards of the American Nurses Credentialing Center (ANCC). The Iowa Board of Nursing and the California Board of Nursing
will honor ANCC continuing education credits for face-to-face programs held outside Iowa and California, or for ANCC-approved
online recorded courses taken in a self-study format.
Accreditation Statement
CHI Health Nebraska Heart Hospital Professional Development Team is an approved provider of continuing nursing education by the Midwest Multistate
Division, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation
Disclosures
The Midwest Multistate Division requires the disclosure of anyone who is in a position to control the content of an educational activity. All relevant
financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. Each faculty
and planning committee member has indicated there they have no financial affiliations that are a conflict of interest.
Resolution of Conflict of Interest
Nebraska Heart Hospital has implemented processes to resolve any potential conflicts of interest for each continuing education activity in order to help
ensure content objectivity, independence, fair balance, and the content that is aligned with the interest of the public. This review is done by committee
and/or peer review.
Faculty/Planning Committee Disclosures
Each of the planning committee members as well as Sara Stevenson, presenting in this webinar, have listed no financial interest/arrangement or affiliation
that would be considered a conflict of interest.
Financial Support
This program is not supported by any commercial or financial interest.
Planning Committee
Karissa Mercurio, MSN, RN; PharmD, BCACP
Privacy and Confidentiality Policy
We respect, and are committed to protecting, your privacy. We will not sell your personally identifiable information to anyone.
Questions?
If you have questions, please call Nebraska Heart Hospital Education at 402.328.3667 or email NHHEducationDept@neheart.com.
Date of Release: March 6th 2015
Date of Review: March 2016
Expiration Date: March 2017
Target Audience
This activity is intended for Nurses and Nurse Practitioners
Overall Educational Objectives
Post-Acute Care of the Coronary Artery Bypass Graft Patient
After completing this educational activity and post-test, participants should be able to:
•
Recognize indications, recommended doses, and side effects of the 3 new oral anticoagulants
•
Identify possible food and drug interactions for the 3 new oral anticoagulants
•
Compare novel anticoagulants with standard warfarin therapy
•
Review teaching points for patient education, including financial resources
Copyright 2014 Nebraska Heart Hospital